ImmunityBio, Inc. IBRX Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s other accrued liabilities?
- ImmunityBio, Inc. (IBRX) reported other accrued liabilities of $2.45M in Q1 2026.
- How has ImmunityBio, Inc.'s other accrued liabilities changed year-over-year?
- ImmunityBio, Inc.'s other accrued liabilities decreased by 7.6% year-over-year, from $2.65M to $2.45M.
- What is the long-term trend for ImmunityBio, Inc.'s other accrued liabilities?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s other accrued liabilities has grown at a 21.0% compound annual growth rate (CAGR), from $1.19M to $3.07M.